BACKGROUND: Despite advances in safety, tolerability, and decreased pill burden for human immunodeficiency virus (HIV) antiretroviral therapy (ART), nonadherence continues to be a major cause of HIV-related morbidity and mortality. Adherence to these medications presents particular challenges because persons living with HIV (PLWH) must use medication more consistently (≥ 95%) than persons with other chronic diseases, such as hypertension or diabetes mellitus (≥ 80%).
RESULTS:
The study included 865 PLWH, who filled 1,943 antiviral prescriptions with an average PDC of 84.5%. However, only 40% of patients had high enough adherence to achieve therapeutic benefits based on a criterion of at least 95% of scheduled doses taken. When separated by regimen, 282 patients filled single-tablet once-daily regimens; 295 patients filled multitablet once-daily regimens; and 288 patients filled multitablet twice-daily regimens. The calculated PDC of PLWH on a single-tablet once-daily regimen was 89.7% versus 81.0% for PLWH on a multitablet once-daily regimen (P < 0.001). The average PDC for PLWH (n = 269) who filled 460 scheduled blood pressure prescriptions was 82.7%. The average PDC for PLWH (n = 295) filling 467 scheduled mental health prescriptions was 81.7%. This difference was statistically significant in adherence between ART and blood pressure medications of 2.5% (P = 0.013) and a difference between ART and scheduled mental health medications of 3.03% (P = 0.002).
For the comparator group of similar patients without HIV, 895 patients filled 1,398 scheduled blood pressure medications, with an average adherence of 83.8%. The difference between groups was not statistically significant (P = 0.390). For scheduled mental health medications in the comparator group, there were 666 patients filling 828 prescriptions. The comparator group had a higher average PDC than PLWH, with 85.1% versus 81.7%, respectively (P = 0.009).
CONCLUSIONS: Based on average PDC, PLWH filling prescriptions at the University of Colorado Hospital Infectious Disease Group Practice pharmacy
• Adherence has a strong direct effect on human immunodeficiency virus (HIV) disease progression and on survival.
• 95% medication adherence is recommended for persons living with HIV (PLWH) who are on HIV antiretroviral therapy (ART).
• Single-tablet regimens have been shown to increase adherence in other studies.
What is already known about this subject
• Based on proportion of days covered, PLWH filling at an infectious diseases specialty pharmacy had an average adherence of 84.5% to ART scheduled doses. However, only 40% of patients were adherent at the needed ≥ 95% level for therapeutic effects.
• PLWH were more adherent to single-tablet once-daily regimens than to multitablet once-daily regimens or multitablet twice-daily regimens.
• Adherence in PLWH to HIV ART was better than the same patients' adherence to scheduled blood pressure and scheduled mental health medications.
• Adherence in PLWH to scheduled blood pressure medications was similar to adherence in a non-HIV-infected patient population, but adherence to scheduled mental health medications was slightly worse.
What this study adds
had an adherence of 84.5% to ART. However, only 40% of patients were adherent at the needed 95% level for therapeutic effects. Additionally, PLWH were more adherent to single-tablet once-daily regimens than to multitablet once-daily regimens or multitablet twice-daily regimens. Adherence in PLWH to HIV ART was better than the same patients' adherence to scheduled blood pressure and scheduled mental health medications. Levels of adherence still need to be improved to optimal to reduce rates of resistance and maximize therapeutic durability of selected regimens. When analyzed with the comparator group, adherence in PLWH to scheduled blood pressure medications was similar, but adherence to scheduled mental health medications was slightly worse. Further work is needed to address nonadherence among PLWH, including their adherence both to ART and to medications prescribed for other chronic diseases.
ART. 13 In addition, about 20% of people initially prescribed ART do not actually begin treatment.
14 Although there is some variability across studies, and patients in randomized controlled trials often have higher adherence rates, similarly poor adherence has been found in studies measuring adherence via retrospective self-report measures, 15 electronic medication-cap monitoring devices, 16 participant reports collected in realtime, 17 pill counts, 18 pharmacy records such as health insurance claims data, 19 and therapeutic drug level monitoring. 20 As treatment regimens simplify for HIV, researchers and practitioners are examining the effects of dosing schedules and pill burden on a patient's adherence. A large retrospective study by Cohen et al. (2013) used Medicaid claims data to compare total medical costs and adherence rates with pill burden and dosing schedule. 21 Single-tablet regimens showed increased adherence rates by calculation of medication possession ratio. 21 Additionally, Gianotti et al. (2013) showed an increase in selfreported adherence for patients on single-tablet once-daily HIV regimens. 22 
■■ Methods
In this retrospective review, we examined outpatient pharmacy prescription fill records at University of Colorado Hospital outpatient pharmacies, in order to quantify PLWH's adherence rates to ART and other medication classes. This academic medical center has a dedicated, infectious disease outpatient pharmacy, the Infectious Disease Group Practice (IDGP) pharmacy, as well as multiple outpatient pharmacies throughout the health system. The objective of the study was to quantify PLWH's overall adherence rates to ART, scheduled blood pressure medications, or scheduled mental health medications. Next, we measured how many of our patients were able to reach the target adherence level for each medication-95% for ART and 80% for all others. We also examined how pill burden and dosing schedule affected adherence. Finally, to compare adherence rates of PLWH with other local patients, we analyzed patients who filled scheduled blood pressure medications or scheduled mental health medications (but not HIV medications) at another academic medical center outpatient pharmacy.
Participants
Patients on any prescribed HIV ART, scheduled prescription blood pressure medication, or scheduled prescription mental health medication filled between March 1, 2012, and March 31, 2013, were included in our analysis of data from outpatient pharmacy fill data. Patients under the age of 18 (date of birth on or after March 1, 1994) were excluded. Because the formula calculated the adherence rate using multiple fill dates for a prescription, any prescription that was not refilled was excluded from the analysis. Additionally, patients who filled multiple or incomplete regimens due to study involvement or obtaining ART from other pharmacies during the study analysis were D espite improvements in pharmaceutical products' safety, efficacy, and convenience over the past 30 years, nonadherence remains common among patients taking medications for chronic disease states such as hypertension or diabetes mellitus. [1] [2] [3] [4] Patients with serious or life-threatening medical conditions may be more adherent to prescribed medications initially, but this effect generally diminishes over time as the initial crisis of diagnosis passes. For this reason, the eventual decline in medication adherence is similar across different disease states. 4 The cost of treatment, the complexity of treatment, and the severity of adverse drug events are among the most commonly cited factors that affect adherence. Psychological factors, such as the perceived cost-benefit of treatment, also play a significant role and limit the strength of these factors' effects. 3, 4 Patients' demographic characteristics are generally unrelated to adherence. [2] [3] [4] Adherence to antiretroviral therapy (ART) for human immunodeficiency virus (HIV) presents particularly great challenges because persons living with HIV (PLWH) must use medication more consistently than persons with other chronic diseases. Although 80% adherence is generally sufficient for medication regimens, similar levels of ART adherence can rapidly lead to drug resistance.
1,2 In 1 study of protease inhibitor (PI) drugs, maximum treatment resistance occurred at 87% adherence. 5 Older "unboosted" PI regimens generally have a low barrier to resistance, 6 while newer "boosted" PI regimens are slightly more forgiving. 7 Because ART medications belong to specific drug classes, nonadherence to 1 drug may produce cross-resistance and further limit treatment options. ART nonadherence thereby creates a cycle where increasingly complex regimens are required. This increased regimen complexity further disrupts adherence and leads to more drug resistance. 8 For these reasons, continuous adherence to at least 95% of doses is generally recommended for maximum ART efficacy, regardless of regimen. Adherence support is an important component of overall treatment of PLWH. 9 ART nonadherence has a strong direct effect on HIV disease progression and on survival. 9 In 1 study, PLWH with CD4 counts < 200 cells/cc 3 who discontinued ART had a risk of disease progression 5 times greater than that of PLWH with similar CD4 counts who took their medications consistently. 8 The consequences of nonadherence can also be measured in terms of health care resources, with nonadherent PLWH having an average of 12.9 hospital days per 1,000, compared with adherent patients' rate of 2.6 days per 1,000, as well as increased opportunistic infections and mortality. 10 ART nonadherence is one of the major remaining causes of HIV-related morbidity and mortality among PLWH and is likely the most preventable reason for death in individuals currently infected with HIV. 11, 12 PLWH's reported adherence to ART varies across studies, but a recent meta-analysis found that adherence generally fell to 50%-70% during the first 6 months after PLWH initiated
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excluded. Blood pressure or mental health medication classes that may be taken intermittently, such as nitroglycerine tablets, benzodiazepines, or sleep aids, were excluded from this analysis.
Measures
With the increased implementation of electronic medical records, pharmacy fill data are increasingly being used to measure adherence. The proportion of days covered (PDC) examines the number of days in a given period of time the patient possessed medication that theoretically could have been taken. PDC can account for multiple prescriptions, "gap days" between fills, and "overlap" days where the patient filled early. In addition to numerous other studies, the Centers for Medicare and Medicaid Services has implemented use of the PDC for adherence analyses.
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Procedure
To measure adherence in our patient population, an outpatient fill record report was created with the assistance of an Information Services System analyst. The outpatient pharmacies used Epic Willow Ambulatory Care (Epic, Verona, WI) dispensing system for pharmacy fill data, and an Epic Clarity report was built. The report calculated a PDC for each prescription. The exact mechanisms of building a PDC report have previously been described. [30] [31] [32] [33] [34] One difference in our report is that we used a medication identification number (MedID) to identify similar prescriptions of the same drug, compared with most other PDC calculations, which used generic code numbers (GCN) to identify prescriptions with the same drug and the same or different dose. GCNs are obtained through insurance claims data and are not tracked through internal pharmacy prescription fill records. Instead, we used a unique MedID number, which identifies medication prescriptions with the same drug and the same dose.
Analysis
To assess the impact of pill burden and dosing schedule on our patient population, we separated HIV regimens into singletablet once-daily regimens, multitablet once-daily regimens, and multitablet twice-daily regimens. To examine difference in PDC across different HIV medication regimens, a simple linear regression model was fit with PDC as the outcome, and a 3-level variable representing regimen was used as the predictor. For HIV medications, patients with multitablet regimens had multiple medications that were filled each month. Since the medication regimens were a single treatment, the minimum recorded PDC was used to characterize the adherence of the patient to the complete regimen. A second linear regression model was used to determine whether the difference in the proportion of patients with ≥ 95% PDC was significant between categories.
To determine the difference in PDC to blood pressure or mental health medications between patient populations, 2-sample t-tests were performed. For both the HIV and non-HIV medications, an additional logistic regression model was fit to ascertain whether the proportion of patients at goal adherence levels differed by pharmacy.
To determine the statistical significance of differences in PDC for antiretrovirals compared with blood pressure medications or mental health medications in patients who filled prescriptions at the IDGP pharmacy, a linear mixed effects model was used, with patient ID as the fixed factor and the 3 adherence measures within persons as the random factor.
■■ Results
Between March 1, 2012, and March 31, 2013, the IDGP pharmacy filled 2,507 prescriptions for ART, scheduled blood pressure medications, or scheduled mental health medications that fit the above criteria. The average age of the analysis population was 46.62 years (standard deviation = 10.26). The population represented a range of races and ethnicities, with Table 1 ). The average PDC for all patients was 84.5%. When separated by regimen, 282 patients filled single-tablet oncedaily regimens; 295 patients filled multitablet once-daily regimens; and 288 patients filled multitablet twice-daily regimens. The average PDC of PLWH on a single-tablet once-daily regimen was 89.7% versus 81.0% for PLWH on a multitablet oncedaily regimen (P < 0.001; Table 2 ). The percentage of patients with ≥ 95% adherence was 49.3% versus 33.2%, respectively, with an odds ratio of 0.512 (P < 0.001). PLWH on a multitablet twice-daily regimen had an average PDC of 83.1% compared with the 89.7% of PLWH on a single-tablet once-daily regimen (P < 0.001). A significantly greater percentage of PLWH on a single-tablet regimen also reached the goal of ≥ 95% adherence-49.3% compared with 37.8% of PLWH on multitablet twice-daily regimens (P = 0.006). There was not a statistically significant difference in the average PDC of patients filling multitablet once-daily regimens (81.0%) and patients filling multitablet twice-daily regimens (83.1%; P = 0.146).
A total of 269 PLWH filled 460 scheduled blood pressure medication prescriptions, and 295 PLWH filled 467 scheduled mental health prescriptions in the IDGP pharmacy. For PLWH filling scheduled blood pressure medications in the IDGP pharmacy, the average PDC was 82.7% and the percentage of patients with ≥ 80% adherence was 65.8% (Table 3) . For PLWH filling scheduled mental health medications in the IDGP pharmacy, the PDC was 81.7%, and the percentage of patients with ≥ 80% adherence was 63.4%. PLWH were statistically significantly more adherent to their ART medications than to their blood pressure medications, with a difference of 2.5% (P = 0.013; Table 4 ). PLWH were more adherent to their ART medications than to their scheduled mental health medications, with a difference of 3.03% (P = 0.002). Although these were statistically significant, the differences were small and may not be clinically meaningful.
Finally, we compared adherence rates with scheduled blood pressure and mental health medications among PLWH and the comparator group-patients who are not filling HIV ART therapy but are using a University of Colorado Hospital outpatient pharmacy. For scheduled blood pressure medications in the comparator group, there were 895 patients filling 1,398 prescriptions, with an average PDC of 83.8%. The comparator group had a higher average PDC versus PLWH with 83.8% to 82.7% and no statistically significant difference (P = 0.390; Table 3 ). The percentage of patients from the comparator group versus the PLWH who reached the goal of ≥80% adherence was 69.6% versus 65.8% (P = 0.238). For scheduled mental health medications, there were 666 patients filling 828 prescriptions. The comparator group had a higher average PDC than PLWH, with 85.1% versus 81.7%, respectively (P = 0.009). The comparator group also had more patients who met the goal of 80% adherence for mental health medications, 72.8% versus 63.4% (P = 0.003).
■■ Discussion
Although the average PDC for patients taking ART was relatively high in this study, the percentage of patients achieving the recommended 95% adherence level was much lower, despite the potentially very serious consequences of ART nonadherence. Consistent with prior studies across a range of chronic disease states showing that more complex treatments have lower adherence, [1] [2] [3] [4] patients who were prescribed regimens with more than 1 dose of ART medication per day had poorer adherence based on both the average PDC and the percentage of patients attaining ≥ 95% adherence.
PLWH at a specialty infectious disease clinic had a level of ART adherence that was better than their adherence to concurrently prescribed blood pressure medication or mental health medications. This finding is consistent with the idea that patients are more adherent to treatments for more severe chronic diseases, 3 but this difference was not large, which is also consistent with prior research. 4 However, more patients achieved a therapeutic level of other categories of medications (≥ 80%) than the percentage receiving the recommended dose of ART (≥ 95%). Perhaps this difference is because the target adherence level for other medication classes was easier to reach.
There was no difference in adherence to scheduled blood pressure medications between patients at a Ryan White-funded specialty clinic and demographically similar patients without HIV who were seen at an outpatient pharmacy in the same area. However, there was a small but statistically significant difference in the adherence to scheduled mental health medications between these 2 groups, with worse adherence among PLWH. There are a number of factors that could contribute to this difference that could not be measured in this study, including number and types of mental health or substance abuse diagnoses or the number of patients who are on antipsychotics, which can be associated with more adverse events than antidepressants. Further study into this difference is warranted.
Limitations
One limitation of the current study was the use of only 1 medication adherence metric. Although the PDC is a best-practice method for identifying nonadherence based on pharmacy fill data, and pharmacy-based measures are generally considered valid, 4 no adherence measure is perfectly accurate, and experts generally recommend the use of multiple approaches. 35 Further study using additional measures such as self-report and medication event monitoring systems is therefore recommended. Another limitation is the data available from the pharmacy prescription fill records. Baseline patient characteristics, such as past medication regimens, length of time on current regimen, number of years infected, or number of diagnosed comorbidities, could not be gathered from the fill data. These factors could have influenced adherence and were not accounted for in this study. A third limitation was the confounding of treatment site with patient population in the comparisons of PLWH versus other patients without HIV. Because the Ryan White program funds extra services not found in general practice, such as mental health, case management, and clinical pharmacy support in the same location as primary care, it is impossible to know what the adherence for PLWH would be like in a treatment setting comparable to that used by the comparator group. One possibility is that these supports are necessary for achieving the equivalent levels of adherence demonstrated in the current study and that PLWH would actually have lower adherence if treated in a less integrated care setting. A strength of the current study was the availability of a large sample with archival pharmacy data, limiting the possibility of reactive assessment effects on adherence and increasing confidence in the generalizability of results. However, findings are limited to the population of PLWH in the Denver, Colorado, area, who are more often white and men who have sex with men than the demographics of the U.S. HIV epidemic overall.
■■ Conclusions
Based on PDC, PLWH filling at the IDGP pharmacy had an average adherence of 84.5% to ART. However, only 40% of patients were adherent at the desired ≥ 95% level for therapeutic effects. Additionally, PLWH were more adherent to singletablet once-daily regimens than to multitablet once-daily regimens or multitablet twice-daily regimens. Adherence in PLWH to HIV ART was better than the same patients' adherence to scheduled blood pressure and scheduled mental health medications. When compared with a different patient group, adherence in PLWH to scheduled blood pressure medications was similar, but adherence to scheduled mental health medications was slightly worse. Further work is needed to address nonadherence among PLWH, including their adherence both to ART and to medications prescribed for other chronic diseases.
